Literature DB >> 22549369

The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden.

Johan Nilsson1, Svante Östling, Margda Waern, Björn Karlsson, Robert Sigström, Xinxin Guo, Ingmar Skoog.   

Abstract

OBJECTIVE: To examine the 1-month prevalence of generalized anxiety disorder (GAD) according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), Diagnostic and Statistical Manual of Mental, Fifth Edition (DSM-V), and International Classification of Diseases, Tenth Revision (ICD-10), and the overlap between these criteria, in a population sample of 75-year-olds. We also aimed to examine comorbidity between GAD and other psychiatric diagnoses, such as depression.
METHOD: During 2005-2006, a comprehensive semistructured psychiatric interview was conducted by trained nurses in a representative population sample of 75-year-olds without dementia in Gothenburg, Sweden (N = 777; 299 men and 478 women). All psychiatric diagnoses were made according to DSM-IV. GAD was also diagnosed according to ICD-10 and DSM-V.
RESULTS: The 1-month prevalence of GAD was 4.1% (N = 32) according to DSM-IV, 4.5% (N = 35) according to DSM-V, and 3.7% (N = 29) according to ICD-10. Only 46.9% of those with DSM-IV GAD fulfilled ICD-10 criteria, and only 51.7% and 44.8% of those with ICD-10 GAD fulfilled DSM-IV/V criteria. Instead, 84.4% and 74.3% of those with DSM-IV/V GAD and 89.7% of those with ICD-10 GAD had depression. Also other psychiatric diagnoses were common in those with ICD-10 and DSM-IV GAD. Only a small minority with GAD, irrespective of criteria, had no other comorbid psychiatric disorder. ICD-10 GAD was related to an increased mortality rate.
CONCLUSIONS: While GAD was common in 75-year-olds, DSM-IV/V and ICD-10 captured different individuals. Current definitions of GAD may comprise two different expressions of the disease. There was greater congruence between GAD in either classification system and depression than between DSM-IV/V GAD and ICD-10 GAD, emphasizing the close link between these entities. 2012 American Association for Geriatric Psychiatry

Entities:  

Mesh:

Year:  2012        PMID: 22549369     DOI: 10.1097/JGP.0b013e318252e749

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

Review 1.  Anxiety disorders and all-cause mortality: systematic review and meta-analysis.

Authors:  Beyon Miloyan; Adam Bulley; Karen Bandeen-Roche; William W Eaton; Daniela C Gonçalves-Bradley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-09-14       Impact factor: 4.328

2.  Alcohol use, anxiety, and insomnia in older adults with generalized anxiety disorder.

Authors:  M Cristina Ivan; Amber B Amspoker; Michael R Nadorff; Mark E Kunik; Jeffrey A Cully; Nancy Wilson; Jessica Calleo; Cynthia Kraus-Schuman; Melinda A Stanley
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-20       Impact factor: 4.105

3.  Acupuncture for anxiety: A protocol for a systematic review of controlled trials.

Authors:  Sung-Youl Choi; Geun-Woo Kim
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

4.  Psychiatric diagnoses in older people with intellectual disability in comparison with the general population: a register study.

Authors:  A Axmon; P Björne; L Nylander; G Ahlström
Journal:  Epidemiol Psychiatr Sci       Date:  2017-02-23       Impact factor: 6.892

5.  High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health.

Authors:  Axel C Carlsson; Per Wändell; Urban Ösby; Ramin Zarrinkoub; Björn Wettermark; Gunnar Ljunggren
Journal:  BMC Public Health       Date:  2013-07-18       Impact factor: 3.295

6.  Few Sex Differences in Hospitalized Suicide Attempters Aged 70 and Above.

Authors:  Stefan Wiktorsson; Therese Rydberg Sterner; Madeleine Mellqvist Fässberg; Ingmar Skoog; Anne Ingeborg Berg; Paul Duberstein; Kimberly Van Orden; Margda Waern
Journal:  Int J Environ Res Public Health       Date:  2018-01-16       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.